drug discovery, distilled

Discover powerful ideas to make informed decisions.

Get access to the latest insights and complete Drug Hunter library, created by scientists for scientists, with a Premium Drug Hunter membership.

try it yourself:

Tell us how to reach you to discover more in a free trial.

“Drug Hunter saves me days, if not weeks of reading each month.”

-TOP 10 PHARMA R&D SITE HEAD

“I find your website really useful, especially the case studies. The chemists and I use it and it helps us keep our finger on the pulse of such an evolving field.”

Steven Van der Plas

Director, Medicinal Chemistry, iTEOS Therapeutics
“Drug Hunter has been great. I regularly check with my team and they all say they like it and use it. My team has benefited from this site with keeping up to date of the latest and greatest. Drug Hunter provides facts, data and information that we can learn from. I have even used some of the sites info in my group meetings.”

Anthony Romero

Director, Head of Chemistry, ORIC Pharma
“I think the content is VERY comprehensive and caters to a wide audience ranging from early stage drug discovery scientists to seasoned drug hunters, whether that be in smaller biotechs or large pharma companies. The standout feature for me is the “Molecules of the Month”, as it serves as a source of inspiration for coming up with new design ideas for one’s own projects. I…

Daljit Matharu

Sr. Scientist, Large Pharma
“Firstly, I would like to thank you for the great work that you are doing. I am an avid follower of the Drug Hunter website and find the resources provided to be invaluable. The PK cheat sheet, Topliss tree information, and concise updates on industry developments are particularly noteworthy.”

Nilesh Zaware

Principal Scientist, Halda Therapeutics
“Your article prompted me to obtain access to your “Premium” collection and I was pleasantly surprised to discover multiple examples that were high quality, even though they were not peer reviewed publications. I then spent some more time on your site and was pleased to discover that it included resources useful to any medicinal chemist.”

Peter Bernstein

Principal, SAB Member, Editor
“Drug Hunter helps keep me up to date with the scientific literature and saves me so much valuable time. Please continue the excellent work!”

Vincent Guerlavais

Senior Director of Medicinal Chemistry, Sarepta Therapeutics / Publicly Listed Biotech
“I like Drug Hunter! I realize that the team puts so much time and effort into this work and it is not easy work. It is a key opinion leader in the industry. I want Drug Hunter to go on forever. It’s really good!”

Mark Baik

Founder and CEO, Arum Therapeutics / Privately Held Biotech
“When I need to find information, I know that I can find it on Drug Hunter. This is what was always missing in our field. I’ve been designing drugs for years and the most frustrating part is learning on your own. You may need to go through hundreds of articles to find the information you need. Drug Hunter cuts down on a lot of this!”

Berenger Biannic

Associate Director, Drug Discovery, Essa Pharma / Publicly Listed Biotech
“I like that the content is written in a straightforward style.”

Ryan Henry

Associate Director, Aleksia Therapeutics
“Drug Hunter has a great overview of what is happening in our field, saves time on scouring through news feeds, literature and irrelevant stuff that comes up. It is a tool specifically for people like me to weed out the noise. Big time saver.”

Cyril Bucher

Drug Discovery Scientist, Denali Therapeutics / Publicly Listed Biotech
“I am way more on top of the med. chem literature because of Drug Hunter!”

Benjamin Horning

Senior Scientist, Medicinal Chemistry, Vividion Therapeutics
Personally, I find the premium subscription very useful. As you mentioned in your talk it is hard to find all the information on the latest approvals and trials in a distilled and ready to consume fashion. So, I really appreciate the work done by the DH group.

Karthik Iyer

Principal Scientist, Arrakis Therapeutics

join Premium subscribers at:

AbbVie, GSK, Lilly, Merck, Sanofi, Servier, Boehringer Ingelheim, Roche, Novartis, Pfizer, Incyte, Harvard, Otsuka, Sarepta, Nimbus, Schrodinger, Vividion, Tango, ORIC, ARCH Venture Partners, Third Rock Ventures, RA Capital, Google Ventures (GV), Medicxi, 8VC, and hundreds of others who are saving “days, if not weeks” of reading each month

access Molecules of the Month deep dives

An example of a slide from the Premium slide decks covering 10 molecules each.

Download a Sample

access new drug approval deep dives

Download a Sample

access industry reviews

searchable individual deep dives

and more…

Latest Premium Articles

Frequently Asked Questions

Premium Molecules of the Month slide decks are found linked on every Molecules of the Month page and unlocked when logged in. Recent individual molecule pages also have in-depth information that is site-searchable. Recent premium-only articles and slide decks can be found on the Premium page in the navigation menu.

Yes, a receipt is provided with each membership subscription, and custom invoices for company reimbursement can be obtained downloaded directly from the account page online or by contacting billing@drughunter.com.

Companies, research sites, or departments can purchase access for groups through a corporate account which can easily grant access to subaccounts by company e-mail address.

A large pharma head of research told us her subscription saves her days, if not weeks of time each month. Consider also the value of getting to a candidate faster with an empowered team, and the cost of a single compound or assay that could be avoided with more context.

Between time savings and the value of enriched ideas, it’s more expensive not to have a subscription!

We’re happy to help set up a demo for your team – just contact us at info@drughunter.com

No, all payments are handled by industry-leading third parties such as Stripe or Plaid. We do not store or handle your sensitive information. See Stripe’s documentation for more information: (https://stripe.com/docs/security/stripe)

Yes, please submit the request form on drughunter.com/plans or drughunter.com/contact and a team member will be in touch.

We can work directly with your academic library to set up institutional access. Contact info@drughunter.com if you would like to refer us to your librarian or department.

Companies can pay by credit or debit card, ACH transfer, wire transfer, or check for annual subscriptions. We’ll work directly with your accounting team to get your team set up!

You can cancel your monthly subscription at any time online using the membership portal, and cancellations will reflect in the next billing cycle. Annual plans that are cancelled will also not renew on the next billing cycle.